0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Frataxin Mitochondrial Market Research Report 2025
Published Date: 2025-07-09
|
Report Code: QYRE-Auto-10G10396
Home | Market Reports | Science| Biological Sciences
Global Frataxin Mitochondrial Market Insights Forecast to 2028
BUY CHAPTERS

Global Frataxin Mitochondrial Market Research Report 2025

Code: QYRE-Auto-10G10396
Report
2025-07-09
Pages:88
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Frataxin Mitochondrial Market

The global market for Frataxin Mitochondrial was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) – Frataxin is a protein encoded by the FXN gene. It promotes the biosynthesis of heme and assembly and repair of iron-sulfur clusters by delivering Fe2+ to proteins involved in these pathways. It plays a role in the protection against iron-catalyzed oxidative stress through its ability to catalyze the oxidation of Fe2+ to Fe3.
North American market for Frataxin Mitochondrial is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Frataxin Mitochondrial is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Frataxin Mitochondrial include AavantiBio Inc, Adverum Biotechnologies Inc, Anima Biotech Inc, Biointaxis SL, Cellivery Therapeutics Inc, CRISPR Therapeutics AG, Design Therapeutics Inc, Fratagene Therapeutics Srl, Fulcrum Therapeutics Inc, Jupiter Orphan Therapeutics Inc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Frataxin Mitochondrial, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Frataxin Mitochondrial.
The Frataxin Mitochondrial market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Frataxin Mitochondrial market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Frataxin Mitochondrial manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Frataxin Mitochondrial Market Report

Report Metric Details
Report Name Frataxin Mitochondrial Market
Segment by Type
  • Friedreich Ataxia Protein
  • FXN
  • EC 1.16.3.1
Segment by Application
  • Central Nervous System
  • Cardiovascular
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AavantiBio Inc, Adverum Biotechnologies Inc, Anima Biotech Inc, Biointaxis SL, Cellivery Therapeutics Inc, CRISPR Therapeutics AG, Design Therapeutics Inc, Fratagene Therapeutics Srl, Fulcrum Therapeutics Inc, Jupiter Orphan Therapeutics Inc, Lacerta Therapeutics Inc, Larimar Therapeutics Inc, Novartis Gene Therapies, PTC Therapeutics Inc, Voyager Therapeutics Inc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Frataxin Mitochondrial manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Frataxin Mitochondrial in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Frataxin Mitochondrial Market report?

Ans: The main players in the Frataxin Mitochondrial Market are AavantiBio Inc, Adverum Biotechnologies Inc, Anima Biotech Inc, Biointaxis SL, Cellivery Therapeutics Inc, CRISPR Therapeutics AG, Design Therapeutics Inc, Fratagene Therapeutics Srl, Fulcrum Therapeutics Inc, Jupiter Orphan Therapeutics Inc, Lacerta Therapeutics Inc, Larimar Therapeutics Inc, Novartis Gene Therapies, PTC Therapeutics Inc, Voyager Therapeutics Inc

What are the Application segmentation covered in the Frataxin Mitochondrial Market report?

Ans: The Applications covered in the Frataxin Mitochondrial Market report are Central Nervous System, Cardiovascular

What are the Type segmentation covered in the Frataxin Mitochondrial Market report?

Ans: The Types covered in the Frataxin Mitochondrial Market report are Friedreich Ataxia Protein, FXN, EC 1.16.3.1

1 Frataxin Mitochondrial Market Overview
1.1 Product Definition
1.2 Frataxin Mitochondrial by Type
1.2.1 Global Frataxin Mitochondrial Market Value Comparison by Type (2024 VS 2031)
1.2.2 Friedreich Ataxia Protein
1.2.3 FXN
1.2.4 EC 1.16.3.1
1.3 Frataxin Mitochondrial by Application
1.3.1 Global Frataxin Mitochondrial Market Value by Application (2024 VS 2031)
1.3.2 Central Nervous System
1.3.3 Cardiovascular
1.4 Global Frataxin Mitochondrial Market Size Estimates and Forecasts
1.4.1 Global Frataxin Mitochondrial Revenue 2020-2031
1.4.2 Global Frataxin Mitochondrial Sales 2020-2031
1.4.3 Global Frataxin Mitochondrial Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Frataxin Mitochondrial Market Competition by Manufacturers
2.1 Global Frataxin Mitochondrial Sales Market Share by Manufacturers (2020-2025)
2.2 Global Frataxin Mitochondrial Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Frataxin Mitochondrial Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Frataxin Mitochondrial, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Frataxin Mitochondrial, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Frataxin Mitochondrial, Product Type & Application
2.7 Global Key Manufacturers of Frataxin Mitochondrial, Date of Enter into This Industry
2.8 Global Frataxin Mitochondrial Market Competitive Situation and Trends
2.8.1 Global Frataxin Mitochondrial Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Frataxin Mitochondrial Players Market Share by Revenue
2.8.3 Global Frataxin Mitochondrial Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Frataxin Mitochondrial Market Scenario by Region
3.1 Global Frataxin Mitochondrial Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Frataxin Mitochondrial Sales by Region: 2020-2031
3.2.1 Global Frataxin Mitochondrial Sales by Region: 2020-2025
3.2.2 Global Frataxin Mitochondrial Sales by Region: 2026-2031
3.3 Global Frataxin Mitochondrial Revenue by Region: 2020-2031
3.3.1 Global Frataxin Mitochondrial Revenue by Region: 2020-2025
3.3.2 Global Frataxin Mitochondrial Revenue by Region: 2026-2031
3.4 North America Frataxin Mitochondrial Market Facts & Figures by Country
3.4.1 North America Frataxin Mitochondrial Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Frataxin Mitochondrial Sales by Country (2020-2031)
3.4.3 North America Frataxin Mitochondrial Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Frataxin Mitochondrial Market Facts & Figures by Country
3.5.1 Europe Frataxin Mitochondrial Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Frataxin Mitochondrial Sales by Country (2020-2031)
3.5.3 Europe Frataxin Mitochondrial Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Frataxin Mitochondrial Market Facts & Figures by Region
3.6.1 Asia Pacific Frataxin Mitochondrial Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Frataxin Mitochondrial Sales by Region (2020-2031)
3.6.3 Asia Pacific Frataxin Mitochondrial Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Frataxin Mitochondrial Market Facts & Figures by Country
3.7.1 Latin America Frataxin Mitochondrial Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Frataxin Mitochondrial Sales by Country (2020-2031)
3.7.3 Latin America Frataxin Mitochondrial Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Frataxin Mitochondrial Market Facts & Figures by Country
3.8.1 Middle East and Africa Frataxin Mitochondrial Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Frataxin Mitochondrial Sales by Country (2020-2031)
3.8.3 Middle East and Africa Frataxin Mitochondrial Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Frataxin Mitochondrial Sales by Type (2020-2031)
4.1.1 Global Frataxin Mitochondrial Sales by Type (2020-2025)
4.1.2 Global Frataxin Mitochondrial Sales by Type (2026-2031)
4.1.3 Global Frataxin Mitochondrial Sales Market Share by Type (2020-2031)
4.2 Global Frataxin Mitochondrial Revenue by Type (2020-2031)
4.2.1 Global Frataxin Mitochondrial Revenue by Type (2020-2025)
4.2.2 Global Frataxin Mitochondrial Revenue by Type (2026-2031)
4.2.3 Global Frataxin Mitochondrial Revenue Market Share by Type (2020-2031)
4.3 Global Frataxin Mitochondrial Price by Type (2020-2031)
5 Segment by Application
5.1 Global Frataxin Mitochondrial Sales by Application (2020-2031)
5.1.1 Global Frataxin Mitochondrial Sales by Application (2020-2025)
5.1.2 Global Frataxin Mitochondrial Sales by Application (2026-2031)
5.1.3 Global Frataxin Mitochondrial Sales Market Share by Application (2020-2031)
5.2 Global Frataxin Mitochondrial Revenue by Application (2020-2031)
5.2.1 Global Frataxin Mitochondrial Revenue by Application (2020-2025)
5.2.2 Global Frataxin Mitochondrial Revenue by Application (2026-2031)
5.2.3 Global Frataxin Mitochondrial Revenue Market Share by Application (2020-2031)
5.3 Global Frataxin Mitochondrial Price by Application (2020-2031)
6 Key Companies Profiled
6.1 AavantiBio Inc
6.1.1 AavantiBio Inc Company Information
6.1.2 AavantiBio Inc Description and Business Overview
6.1.3 AavantiBio Inc Frataxin Mitochondrial Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AavantiBio Inc Frataxin Mitochondrial Product Portfolio
6.1.5 AavantiBio Inc Recent Developments/Updates
6.2 Adverum Biotechnologies Inc
6.2.1 Adverum Biotechnologies Inc Company Information
6.2.2 Adverum Biotechnologies Inc Description and Business Overview
6.2.3 Adverum Biotechnologies Inc Frataxin Mitochondrial Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Adverum Biotechnologies Inc Frataxin Mitochondrial Product Portfolio
6.2.5 Adverum Biotechnologies Inc Recent Developments/Updates
6.3 Anima Biotech Inc
6.3.1 Anima Biotech Inc Company Information
6.3.2 Anima Biotech Inc Description and Business Overview
6.3.3 Anima Biotech Inc Frataxin Mitochondrial Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Anima Biotech Inc Frataxin Mitochondrial Product Portfolio
6.3.5 Anima Biotech Inc Recent Developments/Updates
6.4 Biointaxis SL
6.4.1 Biointaxis SL Company Information
6.4.2 Biointaxis SL Description and Business Overview
6.4.3 Biointaxis SL Frataxin Mitochondrial Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Biointaxis SL Frataxin Mitochondrial Product Portfolio
6.4.5 Biointaxis SL Recent Developments/Updates
6.5 Cellivery Therapeutics Inc
6.5.1 Cellivery Therapeutics Inc Company Information
6.5.2 Cellivery Therapeutics Inc Description and Business Overview
6.5.3 Cellivery Therapeutics Inc Frataxin Mitochondrial Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Cellivery Therapeutics Inc Frataxin Mitochondrial Product Portfolio
6.5.5 Cellivery Therapeutics Inc Recent Developments/Updates
6.6 CRISPR Therapeutics AG
6.6.1 CRISPR Therapeutics AG Company Information
6.6.2 CRISPR Therapeutics AG Description and Business Overview
6.6.3 CRISPR Therapeutics AG Frataxin Mitochondrial Sales, Revenue and Gross Margin (2020-2025)
6.6.4 CRISPR Therapeutics AG Frataxin Mitochondrial Product Portfolio
6.6.5 CRISPR Therapeutics AG Recent Developments/Updates
6.7 Design Therapeutics Inc
6.7.1 Design Therapeutics Inc Company Information
6.7.2 Design Therapeutics Inc Description and Business Overview
6.7.3 Design Therapeutics Inc Frataxin Mitochondrial Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Design Therapeutics Inc Frataxin Mitochondrial Product Portfolio
6.7.5 Design Therapeutics Inc Recent Developments/Updates
6.8 Fratagene Therapeutics Srl
6.8.1 Fratagene Therapeutics Srl Company Information
6.8.2 Fratagene Therapeutics Srl Description and Business Overview
6.8.3 Fratagene Therapeutics Srl Frataxin Mitochondrial Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Fratagene Therapeutics Srl Frataxin Mitochondrial Product Portfolio
6.8.5 Fratagene Therapeutics Srl Recent Developments/Updates
6.9 Fulcrum Therapeutics Inc
6.9.1 Fulcrum Therapeutics Inc Company Information
6.9.2 Fulcrum Therapeutics Inc Description and Business Overview
6.9.3 Fulcrum Therapeutics Inc Frataxin Mitochondrial Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Fulcrum Therapeutics Inc Frataxin Mitochondrial Product Portfolio
6.9.5 Fulcrum Therapeutics Inc Recent Developments/Updates
6.10 Jupiter Orphan Therapeutics Inc
6.10.1 Jupiter Orphan Therapeutics Inc Company Information
6.10.2 Jupiter Orphan Therapeutics Inc Description and Business Overview
6.10.3 Jupiter Orphan Therapeutics Inc Frataxin Mitochondrial Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Jupiter Orphan Therapeutics Inc Frataxin Mitochondrial Product Portfolio
6.10.5 Jupiter Orphan Therapeutics Inc Recent Developments/Updates
6.11 Lacerta Therapeutics Inc
6.11.1 Lacerta Therapeutics Inc Company Information
6.11.2 Lacerta Therapeutics Inc Description and Business Overview
6.11.3 Lacerta Therapeutics Inc Frataxin Mitochondrial Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Lacerta Therapeutics Inc Frataxin Mitochondrial Product Portfolio
6.11.5 Lacerta Therapeutics Inc Recent Developments/Updates
6.12 Larimar Therapeutics Inc
6.12.1 Larimar Therapeutics Inc Company Information
6.12.2 Larimar Therapeutics Inc Description and Business Overview
6.12.3 Larimar Therapeutics Inc Frataxin Mitochondrial Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Larimar Therapeutics Inc Frataxin Mitochondrial Product Portfolio
6.12.5 Larimar Therapeutics Inc Recent Developments/Updates
6.13 Novartis Gene Therapies
6.13.1 Novartis Gene Therapies Company Information
6.13.2 Novartis Gene Therapies Description and Business Overview
6.13.3 Novartis Gene Therapies Frataxin Mitochondrial Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Novartis Gene Therapies Frataxin Mitochondrial Product Portfolio
6.13.5 Novartis Gene Therapies Recent Developments/Updates
6.14 PTC Therapeutics Inc
6.14.1 PTC Therapeutics Inc Company Information
6.14.2 PTC Therapeutics Inc Description and Business Overview
6.14.3 PTC Therapeutics Inc Frataxin Mitochondrial Sales, Revenue and Gross Margin (2020-2025)
6.14.4 PTC Therapeutics Inc Frataxin Mitochondrial Product Portfolio
6.14.5 PTC Therapeutics Inc Recent Developments/Updates
6.15 Voyager Therapeutics Inc
6.15.1 Voyager Therapeutics Inc Company Information
6.15.2 Voyager Therapeutics Inc Description and Business Overview
6.15.3 Voyager Therapeutics Inc Frataxin Mitochondrial Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Voyager Therapeutics Inc Frataxin Mitochondrial Product Portfolio
6.15.5 Voyager Therapeutics Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Frataxin Mitochondrial Industry Chain Analysis
7.2 Frataxin Mitochondrial Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Frataxin Mitochondrial Production Mode & Process Analysis
7.4 Frataxin Mitochondrial Sales and Marketing
7.4.1 Frataxin Mitochondrial Sales Channels
7.4.2 Frataxin Mitochondrial Distributors
7.5 Frataxin Mitochondrial Customer Analysis
8 Frataxin Mitochondrial Market Dynamics
8.1 Frataxin Mitochondrial Industry Trends
8.2 Frataxin Mitochondrial Market Drivers
8.3 Frataxin Mitochondrial Market Challenges
8.4 Frataxin Mitochondrial Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Frataxin Mitochondrial Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Frataxin Mitochondrial Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Frataxin Mitochondrial Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Frataxin Mitochondrial Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Frataxin Mitochondrial Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Frataxin Mitochondrial Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Frataxin Mitochondrial Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Frataxin Mitochondrial Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Frataxin Mitochondrial, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Frataxin Mitochondrial, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Frataxin Mitochondrial, Product Type & Application
 Table 12. Global Key Manufacturers of Frataxin Mitochondrial, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Frataxin Mitochondrial by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Frataxin Mitochondrial as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Frataxin Mitochondrial Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Frataxin Mitochondrial Sales by Region (2020-2025) & (K Units)
 Table 18. Global Frataxin Mitochondrial Sales Market Share by Region (2020-2025)
 Table 19. Global Frataxin Mitochondrial Sales by Region (2026-2031) & (K Units)
 Table 20. Global Frataxin Mitochondrial Sales Market Share by Region (2026-2031)
 Table 21. Global Frataxin Mitochondrial Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Frataxin Mitochondrial Revenue Market Share by Region (2020-2025)
 Table 23. Global Frataxin Mitochondrial Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Frataxin Mitochondrial Revenue Market Share by Region (2026-2031)
 Table 25. North America Frataxin Mitochondrial Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Frataxin Mitochondrial Sales by Country (2020-2025) & (K Units)
 Table 27. North America Frataxin Mitochondrial Sales by Country (2026-2031) & (K Units)
 Table 28. North America Frataxin Mitochondrial Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Frataxin Mitochondrial Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Frataxin Mitochondrial Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Frataxin Mitochondrial Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Frataxin Mitochondrial Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Frataxin Mitochondrial Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Frataxin Mitochondrial Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Frataxin Mitochondrial Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Frataxin Mitochondrial Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Frataxin Mitochondrial Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Frataxin Mitochondrial Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Frataxin Mitochondrial Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Frataxin Mitochondrial Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Frataxin Mitochondrial Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Frataxin Mitochondrial Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Frataxin Mitochondrial Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Frataxin Mitochondrial Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Frataxin Mitochondrial Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Frataxin Mitochondrial Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Frataxin Mitochondrial Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Frataxin Mitochondrial Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Frataxin Mitochondrial Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Frataxin Mitochondrial Sales (K Units) by Type (2020-2025)
 Table 51. Global Frataxin Mitochondrial Sales (K Units) by Type (2026-2031)
 Table 52. Global Frataxin Mitochondrial Sales Market Share by Type (2020-2025)
 Table 53. Global Frataxin Mitochondrial Sales Market Share by Type (2026-2031)
 Table 54. Global Frataxin Mitochondrial Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Frataxin Mitochondrial Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Frataxin Mitochondrial Revenue Market Share by Type (2020-2025)
 Table 57. Global Frataxin Mitochondrial Revenue Market Share by Type (2026-2031)
 Table 58. Global Frataxin Mitochondrial Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Frataxin Mitochondrial Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Frataxin Mitochondrial Sales (K Units) by Application (2020-2025)
 Table 61. Global Frataxin Mitochondrial Sales (K Units) by Application (2026-2031)
 Table 62. Global Frataxin Mitochondrial Sales Market Share by Application (2020-2025)
 Table 63. Global Frataxin Mitochondrial Sales Market Share by Application (2026-2031)
 Table 64. Global Frataxin Mitochondrial Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Frataxin Mitochondrial Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Frataxin Mitochondrial Revenue Market Share by Application (2020-2025)
 Table 67. Global Frataxin Mitochondrial Revenue Market Share by Application (2026-2031)
 Table 68. Global Frataxin Mitochondrial Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Frataxin Mitochondrial Price (US$/Unit) by Application (2026-2031)
 Table 70. AavantiBio Inc Company Information
 Table 71. AavantiBio Inc Description and Business Overview
 Table 72. AavantiBio Inc Frataxin Mitochondrial Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. AavantiBio Inc Frataxin Mitochondrial Product
 Table 74. AavantiBio Inc Recent Developments/Updates
 Table 75. Adverum Biotechnologies Inc Company Information
 Table 76. Adverum Biotechnologies Inc Description and Business Overview
 Table 77. Adverum Biotechnologies Inc Frataxin Mitochondrial Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Adverum Biotechnologies Inc Frataxin Mitochondrial Product
 Table 79. Adverum Biotechnologies Inc Recent Developments/Updates
 Table 80. Anima Biotech Inc Company Information
 Table 81. Anima Biotech Inc Description and Business Overview
 Table 82. Anima Biotech Inc Frataxin Mitochondrial Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Anima Biotech Inc Frataxin Mitochondrial Product
 Table 84. Anima Biotech Inc Recent Developments/Updates
 Table 85. Biointaxis SL Company Information
 Table 86. Biointaxis SL Description and Business Overview
 Table 87. Biointaxis SL Frataxin Mitochondrial Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Biointaxis SL Frataxin Mitochondrial Product
 Table 89. Biointaxis SL Recent Developments/Updates
 Table 90. Cellivery Therapeutics Inc Company Information
 Table 91. Cellivery Therapeutics Inc Description and Business Overview
 Table 92. Cellivery Therapeutics Inc Frataxin Mitochondrial Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Cellivery Therapeutics Inc Frataxin Mitochondrial Product
 Table 94. Cellivery Therapeutics Inc Recent Developments/Updates
 Table 95. CRISPR Therapeutics AG Company Information
 Table 96. CRISPR Therapeutics AG Description and Business Overview
 Table 97. CRISPR Therapeutics AG Frataxin Mitochondrial Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. CRISPR Therapeutics AG Frataxin Mitochondrial Product
 Table 99. CRISPR Therapeutics AG Recent Developments/Updates
 Table 100. Design Therapeutics Inc Company Information
 Table 101. Design Therapeutics Inc Description and Business Overview
 Table 102. Design Therapeutics Inc Frataxin Mitochondrial Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Design Therapeutics Inc Frataxin Mitochondrial Product
 Table 104. Design Therapeutics Inc Recent Developments/Updates
 Table 105. Fratagene Therapeutics Srl Company Information
 Table 106. Fratagene Therapeutics Srl Description and Business Overview
 Table 107. Fratagene Therapeutics Srl Frataxin Mitochondrial Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Fratagene Therapeutics Srl Frataxin Mitochondrial Product
 Table 109. Fratagene Therapeutics Srl Recent Developments/Updates
 Table 110. Fulcrum Therapeutics Inc Company Information
 Table 111. Fulcrum Therapeutics Inc Description and Business Overview
 Table 112. Fulcrum Therapeutics Inc Frataxin Mitochondrial Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Fulcrum Therapeutics Inc Frataxin Mitochondrial Product
 Table 114. Fulcrum Therapeutics Inc Recent Developments/Updates
 Table 115. Jupiter Orphan Therapeutics Inc Company Information
 Table 116. Jupiter Orphan Therapeutics Inc Description and Business Overview
 Table 117. Jupiter Orphan Therapeutics Inc Frataxin Mitochondrial Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Jupiter Orphan Therapeutics Inc Frataxin Mitochondrial Product
 Table 119. Jupiter Orphan Therapeutics Inc Recent Developments/Updates
 Table 120. Lacerta Therapeutics Inc Company Information
 Table 121. Lacerta Therapeutics Inc Description and Business Overview
 Table 122. Lacerta Therapeutics Inc Frataxin Mitochondrial Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Lacerta Therapeutics Inc Frataxin Mitochondrial Product
 Table 124. Lacerta Therapeutics Inc Recent Developments/Updates
 Table 125. Larimar Therapeutics Inc Company Information
 Table 126. Larimar Therapeutics Inc Description and Business Overview
 Table 127. Larimar Therapeutics Inc Frataxin Mitochondrial Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Larimar Therapeutics Inc Frataxin Mitochondrial Product
 Table 129. Larimar Therapeutics Inc Recent Developments/Updates
 Table 130. Novartis Gene Therapies Company Information
 Table 131. Novartis Gene Therapies Description and Business Overview
 Table 132. Novartis Gene Therapies Frataxin Mitochondrial Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Novartis Gene Therapies Frataxin Mitochondrial Product
 Table 134. Novartis Gene Therapies Recent Developments/Updates
 Table 135. PTC Therapeutics Inc Company Information
 Table 136. PTC Therapeutics Inc Description and Business Overview
 Table 137. PTC Therapeutics Inc Frataxin Mitochondrial Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. PTC Therapeutics Inc Frataxin Mitochondrial Product
 Table 139. PTC Therapeutics Inc Recent Developments/Updates
 Table 140. Voyager Therapeutics Inc Company Information
 Table 141. Voyager Therapeutics Inc Description and Business Overview
 Table 142. Voyager Therapeutics Inc Frataxin Mitochondrial Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Voyager Therapeutics Inc Frataxin Mitochondrial Product
 Table 144. Voyager Therapeutics Inc Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Frataxin Mitochondrial Distributors List
 Table 148. Frataxin Mitochondrial Customers List
 Table 149. Frataxin Mitochondrial Market Trends
 Table 150. Frataxin Mitochondrial Market Drivers
 Table 151. Frataxin Mitochondrial Market Challenges
 Table 152. Frataxin Mitochondrial Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Frataxin Mitochondrial
 Figure 2. Global Frataxin Mitochondrial Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Frataxin Mitochondrial Market Share by Type: 2024 & 2031
 Figure 4. Friedreich Ataxia Protein Product Picture
 Figure 5. FXN Product Picture
 Figure 6. EC 1.16.3.1 Product Picture
 Figure 7. Global Frataxin Mitochondrial Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Frataxin Mitochondrial Market Share by Application: 2024 & 2031
 Figure 9. Central Nervous System
 Figure 10. Cardiovascular
 Figure 11. Global Frataxin Mitochondrial Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Frataxin Mitochondrial Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Frataxin Mitochondrial Sales (2020-2031) & (K Units)
 Figure 14. Global Frataxin Mitochondrial Average Price (US$/Unit) & (2020-2031)
 Figure 15. Frataxin Mitochondrial Report Years Considered
 Figure 16. Frataxin Mitochondrial Sales Share by Manufacturers in 2024
 Figure 17. Global Frataxin Mitochondrial Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Frataxin Mitochondrial Players: Market Share by Revenue in Frataxin Mitochondrial in 2024
 Figure 19. Frataxin Mitochondrial Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Frataxin Mitochondrial Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Frataxin Mitochondrial Sales Market Share by Country (2020-2031)
 Figure 22. North America Frataxin Mitochondrial Revenue Market Share by Country (2020-2031)
 Figure 23. United States Frataxin Mitochondrial Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Frataxin Mitochondrial Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Frataxin Mitochondrial Sales Market Share by Country (2020-2031)
 Figure 26. Europe Frataxin Mitochondrial Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Frataxin Mitochondrial Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Frataxin Mitochondrial Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Frataxin Mitochondrial Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Frataxin Mitochondrial Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Frataxin Mitochondrial Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Frataxin Mitochondrial Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Frataxin Mitochondrial Revenue Market Share by Region (2020-2031)
 Figure 34. China Frataxin Mitochondrial Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Frataxin Mitochondrial Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Frataxin Mitochondrial Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Frataxin Mitochondrial Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Frataxin Mitochondrial Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Frataxin Mitochondrial Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Frataxin Mitochondrial Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Frataxin Mitochondrial Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Frataxin Mitochondrial Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Frataxin Mitochondrial Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Frataxin Mitochondrial Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Frataxin Mitochondrial Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Frataxin Mitochondrial Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Frataxin Mitochondrial Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Frataxin Mitochondrial Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Frataxin Mitochondrial Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Frataxin Mitochondrial Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Frataxin Mitochondrial Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Frataxin Mitochondrial Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Frataxin Mitochondrial by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Frataxin Mitochondrial by Type (2020-2031)
 Figure 55. Global Frataxin Mitochondrial Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Frataxin Mitochondrial by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Frataxin Mitochondrial by Application (2020-2031)
 Figure 58. Global Frataxin Mitochondrial Price (US$/Unit) by Application (2020-2031)
 Figure 59. Frataxin Mitochondrial Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS